No Pfizer COVID-19 vaccines from next week for Canada due to cut in supplies
Pfizer said last week it would slow production in late January and early February because of changes in manufacturing processes, resulting in a supply cut for Canada and European Union nations.;
Ottawa: Pfizer Inc told Canada on Tuesday it will receive no coronavirus vaccines next week, officials said, an unexpected development that promises more pain for provinces already complaining about a shortage of supplies.
Pfizer said last week it would slow production in late January and early February because of changes in manufacturing processes, resulting in a supply cut for Canada and European Union nations.
Canada had already predicted last week that Pfizer shipments would be cut in half over the next month. But Major-General Deny Fortin, who is helping organize the inoculation campaign, said Pfizer had now announced all Canadian deliveries promised for the week starting Jan. 25 would be pushed back into February.
"The effect next week will be severe, more severe than we had initially expected," he told reporters, predicting "a considerable impact" in all 10 provinces.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.